A Systematic Review of the Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation Patients with Diabetes Using a Risk Index

A Systematic Review of the Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation Patients with Diabetes Using a Risk Index

Diabetes mellitus (DM) represents an independent risk factor for chronic AF and is associated with unfavorable outcomes. We aimed to evaluate the efficacy and safety of direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF), with and without diabetes mellitus (DM), using a new...

Full description

Bibliographic Details
Main Authors:	Domenico Acanfora, Marco Matteo Ciccone, Valentina Carlomagno, Pietro Scicchitano, Chiara Acanfora, Alessandro Santo Bortone, Massimo Uguccioni, Gerardo Casucci
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Journal of Clinical Medicine
Subjects:	atrial fibrillation DOACs diabetes mellitus risk index
Online Access:	https://www.mdpi.com/2077-0383/10/13/2924

Similar Items

The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases
by: Domenico Acanfora, et al.
Published: (2021-09-01)

Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients
by: Alessandra M. Campos-Staffico, et al.
Published: (2022-11-01)

Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study
by: Wenlin Xu, et al.
Published: (2023-11-01)

Patients’ and clinicians’ perceptions of oral anticoagulants in atrial fibrillation: a systematic narrative review and meta-analysis
by: Yeyenta Mina Osasu, et al.
Published: (2021-12-01)

Direct Oral Anticoagulants in Patients with Obesity and Atrial Fibrillation: Position Paper of Italian National Association of Hospital Cardiologists (ANMCO)
by: David Mocini, et al.
Published: (2021-09-01)

A Tailored Antithrombotic Approach for Patients with Atrial Fibrillation Presenting with Acute Coronary Syndrome and/or Undergoing PCI: A Case Series
by: Simona Giubilato, et al.
Published: (2022-07-01)

Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion
by: Giuseppe Coppola, et al.
Published: (2019-09-01)

Use and Prescription of Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Multidisciplinary Consensus Document
by: Marco Proietti, et al.
Published: (2022-03-01)

Comparing Efficacy and Safety Between Patients With Atrial Fibrillation Taking Direct Oral Anticoagulants or Warfarin After Direct Oral Anticoagulant Failure
by: Meng‐Tsang Hsieh, et al.
Published: (2023-12-01)

Five Years of Direct Oral Anticoagulants Use in Italy: Adverse Drug Reactions from the Italian National Pharmacovigilance Network
by: Carlo Lavalle, et al.
Published: (2022-06-01)

Inappropriate Underdosing of Direct Oral Anticoagulants in Atrial Fibrillation Patients: Results from the START2-AF Registry
by: Daniela Poli, et al.
Published: (2024-03-01)

Impact of amiodarone on plasma concentration of direct oral anticoagulant in patients with atrial fibrillation
by: Shin-Yi Lin, et al.
Published: (2023-08-01)

Retrospective Comparison of Patients ≥ 80 Years With Atrial Fibrillation Prescribed Either an FDA-Approved Reduced or Full Dose Direct-Acting Oral Anticoagulant
by: Roy Taoutel, et al.
Published: (2022-12-01)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
by: Matej Samoš, et al.
Published: (2022-10-01)

Direct Oral Anticoagulants in Patients on Chronic Dialysis and Concomitant Atrial Fibrillation: A Common Clinical Impasse
by: Nikolaos Ktenopoulos, et al.
Published: (2022-07-01)

Effectiveness and safety of edoxaban versus warfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies
by: Mohammed M. Alsultan, et al.
Published: (2023-11-01)

Incidence of left atrial appendage thrombus despite 3 weeks of anticoagulation and the need for precardioversion echocardiography
by: Marc Erickson, et al.
Published: (2022-09-01)

Medium-term and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation
by: Giuseppe Armentaro, et al.
Published: (2023-07-01)

Oral Anticoagulation in Patients with Chronic Liver Disease
by: Raluca S. Costache, et al.
Published: (2023-02-01)

Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban
by: Liselotte Onelöv, et al.
Published: (2024-03-01)

Changing or Retaining Direct Oral Anticoagulant After Ischemic Stroke Despite Direct Oral Anticoagulant Treatment
by: Shin‐Yi Lin, et al.
Published: (2024-02-01)

An update on applications and limitations of direct oral anticoagulants
by: Sharon Wei, et al.
Published: (2023-04-01)

Concurrent use of statins decreases major bleeding and intracerebral hemorrhage in non-valvular atrial fibrillation patients taking direct oral anticoagulants—A nationwide cohort study
by: Hsin-Hsu Wu, et al.
Published: (2022-08-01)

Prescribing and Safety of Direct-Acting Oral Anticoagulants Compared to Warfarin in Patients with Atrial Fibrillation on Chronic Hemodialysis
by: Estella Davis, et al.
Published: (2020-03-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

Inappropriate dosing of direct oral anticoagulants: findings from a clinical vignette study and physician survey
by: Ahmet Fuat, et al.
Published: (2023-12-01)

Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
by: Darae Ko, et al.
Published: (2021-11-01)

Risk Profiles of New Users of Oral Anticoagulants Between 2011 and 2019 in Germany
by: Voss A, et al.
Published: (2023-07-01)

Oral anticoagulant therapy for older patients with atrial fibrillation
by: Mario Bo, et al.
Published: (2017-09-01)

Anticoagulant therapy in patients with atrial fibrillation and concomitant chronic kidney disease: the results of a prospective study
by: I. S. Daabul, et al.
Published: (2019-04-01)

New Insights into Anticoagulation in Atrial Fibrillation
by: Xiaohan Fan, MD, et al.
Published: (2011-01-01)

Management of anticoagulation in atrial fibrillation patients in Italy: insight from the <i>Atrial Fibrillation-Survey on Anticoagulated Patients Register</i> (AF-START)
by: Daniela Poli, et al.
Published: (2023-06-01)

Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban
by: Tze-Fan Chao, et al.
Published: (2022-12-01)

Do all patients with atrial fibrillation need long-term anticoagulation?
by: Munish Sharma, et al.
Published: (2017-07-01)

Anticoagulants versus Left Atrial Appendage Occlusion in Patients with Atrial Fibrillation and Co-Morbid Thrombocytopenia
by: Wiktoria Kowalska, et al.
Published: (2023-12-01)

The Chinese burden of atrial fibrillation review of atrial fibrillation studies in China
by: Jianshu Song
Published: (2022-11-01)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
by: M. Yu. Gilyarov
Published: (2015-12-01)

Gender Differences in Patients with Atrial Fibrillation Receiving Oral Anticoagulants
by: Jo-Nan Liao, et al.
Published: (2024-03-01)

Association of Depression and Adherence to Oral Anticoagulation in Patients With Atrial Fibrillation
by: Matthew E. Lapa, et al.
Published: (2023-11-01)

Prolonged Secondary Stroke Prevention with Edoxaban: A Long-Term Follow-Up of the SATES Study
by: Irene Scala, et al.
Published: (2023-11-01)